Return
Opportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and US Food and Drug Administration
H
B
W
E
M
R
M
DOI:10.7326/ANNALS-24-02318.png)
Abstract
En
Journal
IF:
15.2
Papers:
4.2W
Citations:
6.5W
